INSIGHTS ON CLINICAL TRIAL DESIGN

• 5 Key Considerations For Choosing The Right ERP

  Selecting an Enterprise Resource Planning (ERP) system is a pivotal decision for life sciences organizations, influencing regulatory compliance, operational efficiency, and long-term growth.

• Building Trust Through Connection: EmVenio At The Atlanta Black Expo

  Engaging with communities in familiar settings helps raise awareness, address concerns, and create a more inclusive foundation for clinical research participation built on dialogue, respect, and long‑term relationships.

• Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study

  This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

• Redefining Vaccine Trial Recruitment

  Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.

• Building Recruitment Into Early-Phase Trial Design

  7/30/2026

  Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.

• Lessons From The Front Lines: Navigating The Operational Challenges Of Next-Generation ADC Trials

  9/22/2026

  See how smarter protocol design and real-time safety monitoring can ease patient burden and keep next-gen ADC oncology trials on track.

• The Healing Power Of Support Groups

  10/20/2025

  Support groups offer emotional strength and connection for patients and caregivers, helping them navigate medical challenges, treatment journeys, and the complexities of chronic conditions.

• ADCs In Oncology Trials Webinar

  10/2/2025

  Whether you are preparing to launch your first ADC study or looking to optimize current programs, this session will deliver practical insights you can put into action immediately.

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  1/31/2025

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.